Duke-NUS brings aboard Novo Nordisk to fund stem cell research program
Kort samengevat
HONG KONG – Denmark's Novo Nordisk A/S has teamed up with Singapore's Duke-NUS Medical School to provide funding for the next three to five years for stem cell-based research aimed at growing heart muscle and retinal cells to treat heart failure and vision loss.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Bioworld.
Lees het volledige bericht ↗